FDA Inspection 770062 — Biomat USA, Inc.

Biomat USA, Inc. — FEI 3006213838

The FDA completed an inspection of Biomat USA, Inc. on Feb 2, 2012 in Indianapolis, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Feb 2, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Indianapolis, IN (United States)